Fingerlakes Wealth Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-1,981
Closed -$225K 87
2024
Q3
$225K Sell
1,981
-28
-1% -$3.33K 0.19% 84
2024
Q2
$249K Buy
2,009
+2
+0.1% +$258 0.22% 80
2024
Q1
$265K Buy
2,007
+13
+0.7% +$1.6K 0.26% 78
2023
Q4
$217K Sell
1,994
-128
-6% -$13.3K 0.23% 82
2023
Q3
$218K Sell
2,122
-55
-3% -$5.93K 0.27% 79
2023
Q2
$251K Sell
2,177
-166
-7% -$18.8K 0.29% 80
2023
Q1
$249K Buy
2,343
+5
+0.2% +$540 0.31% 81
2022
Q4
$259K Buy
2,338
+16
+0.7% +$1.64K 0.36% 78
2022
Q3
$200K Sell
2,322
-159
-6% -$14.2K 0.29% 82
2022
Q2
$226K Sell
2,481
-226
-8% -$20K 0.31% 83
2022
Q1
$222K Buy
2,707
+23
+0.9% +$1.81K 0.26% 91
2021
Q4
$204K Buy
+2,684
New +$214K 0.23% 90

Other funds holding MRK

Fingerlakes Wealth Management's MRK Position: Q4 2024 in Review

Fingerlakes Wealth Management sold out of Merck (MRK) in Q4 2024, closing a stake of 1,981 shares — an estimated $225K sold.

Fingerlakes Wealth Management first reported a position in MRK in Q4 2021 and held it in 12 quarters. The position peaked at $265K in Q1 2024. 3,607 funds tracked by Wall St. Rank hold MRK as of Q4 2024.

  • Fingerlakes Wealth Management reported no remaining Merck position as of Q4 2024 after selling out during the quarter.
  • Fingerlakes Wealth Management sold 1,981 Merck shares in Q4 2024, an estimated $225K.
  • Fingerlakes Wealth Management first reported a position in Merck in Q4 2021 and held it in 12 quarters.
  • Fingerlakes Wealth Management's Merck position peaked at $265K in Q1 2024.
  • 3,607 funds tracked by Wall St. Rank held Merck as of Q4 2024.

Based on Fingerlakes Wealth Management's 13F filing for Q4 2024, filed 3 Feb 2025.